🟢 Korro Bio is trading 10.44% up today with no confirmed company-specific catalyst

Korro Bio is trading 10.44% up at $13.52, with no confirmed company-specific catalyst identified for September 8, 2026.

• An August 27 corporate update announced CEO Ram Aiyar’s participation in the Citi Biopharma Back to School Summit on September 9.
• Aiyar is also scheduled for the Cantor Global Healthcare Conference on September 10.
• The upcoming events may be attracting speculative interest, but a direct connection remains unconfirmed.